BBC Morning Live has broadcast a report highlighting the stigma, hostility and daily struggles faced by mobility scooter users across the UK. The feature, which aired on 30 September, followed ...

Davin Grikis is not an art collector or expert. But when the recruitment specialist found himself between jobs in July, he decided to do some detective work on the painting his wife Holly had ...

Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), ...

Lundbeck has presented new clinical data on eptinezumab at the 2025 International Headache Congress in São Paulo, highlighting its long-term preventive effectiveness in patients severely affected by ...

Miku_Installer works on Windows 10 and 11, 64-bit version. It installs dependencies and tools to use MikuMikuDance and PMX Editor. You need 3 GB of free space for the ...

Anti-calcitonin gene-related peptide monoclonal antibodies (mAbs) demonstrated meaningful and sustained effectiveness in reducing monthly migraine days (MMDs) across three consecutive 1-year treatment ...

Includes full savings & cash ISA best buys... UK interest rates are likely on the move. And that means savers need to check what they earn now. Millions are on pants sub-4% rates and can easily ditch, ...

The use of the calcitonin gene-related peptide (CGRP) antagonist rimegepant 75 mg for 52 weeks showed a favorable safety profile and sustained benefits for migraine prevention in a new open-label ...

Final results from the Phase IV PEARL trial show that 66% of patients treated with Ajovy for episodic migraine and more than half of those treated for chronic migraine who responded during the first ...

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant ...

In a post-hoc analysis of the DELIVER trial, interictal periods were longer with VYEPTI compared to placebo and corresponded to higher patient-reported quality of life outcomes Individuals taking ...